慢性そう痒症治療薬の世界市場レポート 2025年

慢性そう痒症治療薬市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は7.3％で、144億9,000万米ドルに成長します。予測期間中の成長は、認知度の上昇、アトピー性皮膚炎の有病率の増加、個別化医療への注目の高まり、皮膚科疾患の罹患率の上昇、患者人口の増加といった要因に起因すると考えられます。この期間の主な動向としては、革新的医薬品の導入、新規生物製剤や標的療法の開発、技術の発展、先進ドラッグデリバリーシステムの統合、製薬企業と研究機関の提携、遠隔医療を含むデジタルヘルス技術の導入などが挙げられます。

アトピー性皮膚炎の有病率の上昇が慢性そう痒症治療薬市場の成長を牽引すると予想されます。アトピー性皮膚炎（AD）は、発赤、かゆみ、乾燥、炎症などの症状を特徴とする慢性炎症性皮膚疾患です。アトピー性皮膚炎は、アレルギー、喘息、花粉症などの家族歴のある人によく発症します。アトピー性皮膚炎の有病率の増加は、遺伝的素因、環境の変化、生活習慣、衛生仮説、アレルゲン暴露の増加、皮膚マイクロバイオームの不均衡などの要因に起因すると考えられています。慢性そう痒症治療薬は、根本的な炎症経路を標的とし、皮膚刺激を軽減し、患者の快適性を高めることによって、アトピー性皮膚炎に伴う持続的なかゆみを緩和するのに役立ちます。例えば、2022年に国際湿疹協議会が発表したアトピー性皮膚炎の患者数は、全世界で約2億2,300万人であり、そのうち1～4歳の小児は4,300万人でした。その結果、アトピー性皮膚炎の有病率の増加が慢性そう痒症治療薬市場の拡大を牽引しています。

慢性そう痒症治療薬市場の主な企業は、治療効果を向上させ、患者を迅速に救済するために、静脈注射療法などの革新的な治療法の開発に注力しています。静脈注射は、抗ヒスタミン薬や副腎皮質ステロイド薬などの薬剤を血流に直接送り込み、かゆみや炎症を迅速に緩和します。例えば、米国を拠点とするCara Therapeutics Inc.は、2023年9月、パートナー企業である丸石製薬株式会社が、日本における抗ヒスタミン薬やコルチコステロイド薬の製造販売承認を取得したと発表しました。が、日本の厚生労働省からコルスバ静注シリンジの承認を取得したと発表しました。血液透析患者のそう痒症を対象としたこの治療は、第3相臨床試験において、プラセボと比較してかゆみスコアの有意な改善を示し、患者からの忍容性も良好でした。この承認により、丸石製薬とのライセンス契約に基づき、カラ・セラピューティクス社に150万米ドルのマイルストンが支払われることになります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界慢性そう痒症治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の慢性そう痒症治療薬市場：成長率分析
• 世界の慢性そう痒症治療薬市場の実績：規模と成長, 2019-2024
• 世界の慢性そう痒症治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界慢性そう痒症治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の慢性そう痒症治療薬市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチコステロイド
• 抗ヒスタミン剤
• 局所麻酔薬
• 逆刺激剤
• 免疫抑制剤
• カルシニューリン阻害剤
• その他の製品タイプ
• 世界の慢性そう痒症治療薬市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アトピー性皮膚炎
• アレルギー性接触皮膚炎
• 蕁麻疹
• その他の病気の種類
• 世界の慢性そう痒症治療薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• ドラッグストアと小売薬局
• オンラインプロバイダー
• 世界の慢性そう痒症治療薬市場、コルチコステロイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所コルチコステロイド
• 経口コルチコステロイド
• 注射用コルチコステロイド
• 世界の慢性そう痒症治療薬市場抗ヒスタミン薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 第一世代抗ヒスタミン薬
• 第二世代抗ヒスタミン薬
• 世界の慢性そう痒症治療薬市場局所麻酔薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所麻酔薬
• 注射用局所麻酔薬
• 世界の慢性そう痒症治療薬市場、タイプ別抗刺激剤のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• メントールベースの抗刺激剤
• 樟脳ベースの抗刺激剤
• 世界の慢性そう痒症治療薬市場免疫抑制剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 全身免疫抑制剤
• 局所免疫抑制剤
• 世界の慢性そう痒症治療薬市場カルシニューリン阻害剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• タクロリムスベースの治療
• ピメクロリムスベースの治療
• 世界の慢性そう痒症治療薬市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生物学的療法
• 新たな治療法の出現

第7章 地域別・国別分析

• 世界の慢性そう痒症治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の慢性そう痒症治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 慢性そう痒症治療薬市場：競合情勢
• 慢性そう痒症治療薬市場：企業プロファイル
  • Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Toray Industries Inc.
• CSL Behring LLC
• Regeneron Pharmaceuticals Inc.
• Astellas Pharma Inc.
• Ipsen S.A.
• Incyte Corporation
• Cipla Limited
• H. Lundbeck A/S
• Sumitomo Pharma Co. Ltd.
• Mallinckrodt Pharmaceuticals plc
• Kissei Pharmaceutical Co. Ltd.
• Asana BioSciences LLC
• Vanda Pharmaceuticals Inc.
• Dermavant Sciences Inc.
• Galderma Laboratories L.P.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 慢性そう痒症治療薬市場2029：新たな機会を提供する国
• 慢性そう痒症治療薬市場2029：新たな機会を提供するセグメント
• 慢性そう痒症治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Chronic pruritus therapy refers to treatments designed to manage or relieve persistent itching (pruritus) that lasts for six weeks or more. Managing chronic pruritus involves a combination of therapies tailored to the underlying cause, with treatment adjustments based on the patient's response.

The main product types for chronic pruritus therapeutics include corticosteroids, antihistamines, local anesthetics, counterirritants, immunosuppressants, calcineurin inhibitors, and other treatments. Corticosteroids are medications that reduce inflammation and itching by suppressing the immune system's response, making them effective for treating chronic pruritus and inflammatory skin conditions. These products are used for various conditions, including atopic dermatitis, allergic contact dermatitis, urticaria, and others. They are distributed through multiple channels, such as hospital pharmacies, drug stores, retail pharmacies, and online providers.

The chronic pruritus therapeutics market research report is one of a series of new reports from The Business Research Company that provides chronic pruritus therapeutics market statistics, including the chronic pruritus therapeutics industry global market size, regional shares, competitors with the chronic pruritus therapeutics market share, detailed chronic pruritus therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the chronic pruritus therapeutics industry. This chronic pruritus therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chronic pruritus therapeutics market size has grown strongly in recent years. It will grow from $10.17 billion in 2024 to $10.94 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth during the historic period can be attributed to factors such as the rising prevalence of chronic pruritus, increasing demand for effective treatments, growing regulatory approvals, a rise in product approvals, and an increase in mergers, collaborations, and acquisitions among industry participants.

The chronic pruritus therapeutics market size is expected to see strong growth in the next few years. It will grow to $14.49 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth during the forecast period can be attributed to factors such as rising awareness, the increasing prevalence of atopic dermatitis, a growing focus on personalized medicine, the rising incidence of dermatological conditions, and a growing patient population. Key trends during this period include the introduction of innovative medicines, the development of novel biologics and targeted therapies, technological advancements, the integration of advanced drug delivery systems, collaborations between pharmaceutical companies and research institutions, and the adoption of digital health technologies, including telemedicine.

The rising prevalence of atopic dermatitis is expected to drive the growth of the chronic pruritus therapeutics market. Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by symptoms such as redness, itching, dryness, and irritation. It commonly affects individuals with a family history of allergies, asthma, or hay fever. The increasing prevalence of atopic dermatitis can be attributed to factors such as genetic predisposition, environmental changes, lifestyle habits, the hygiene hypothesis, increased allergen exposure, and imbalances in the skin microbiome. Chronic pruritus therapeutics help alleviate the persistent itching associated with atopic dermatitis by targeting the underlying inflammatory pathways, reducing skin irritation, and enhancing patient comfort. For example, in 2022, the International Eczema Council reported that approximately 223 million people worldwide were living with atopic dermatitis, including 43 million children aged 1-4, emphasizing the condition's high prevalence in early childhood. As a result, the growing prevalence of atopic dermatitis is driving the expansion of the chronic pruritus therapeutics market.

Key companies in the chronic pruritus therapeutics market are focusing on developing innovative treatments, such as intravenous (IV) injection therapies, to improve treatment efficacy and provide quicker relief for patients. IV injections deliver medications such as antihistamines or corticosteroids directly into the bloodstream, offering fast relief from itching and inflammation. For example, in September 2023, Cara Therapeutics Inc., a U.S.-based company, announced that its partner company Maruishi Pharmaceutical Co. Ltd. received approval from Japan's Ministry of Health, Labour and Welfare for the Korsuva IV injection syringe. This treatment, aimed at pruritus in hemodialysis patients, showed significant improvements in itching scores compared to a placebo in Phase 3 clinical trials and was well-tolerated by patients. The approval also triggered a $1.5 million milestone payment to Cara Therapeutics under the terms of their licensing agreement with Maruishi.

In May 2024, Incyte Corporation, a U.S.-based biopharmaceutical company, acquired Escient Pharmaceuticals for $750 million. This acquisition aims to strengthen Incyte's Inflammation and Autoimmunity (IAI) pipeline by integrating innovative therapies targeting severe inflammatory diseases. Escient Pharmaceuticals is a U.S.-based biotechnology company specializing in therapeutics for uremic pruritus.

Major players in the chronic pruritus therapeutics market are Pfizer Incorporated, AbbVie Inc., Sanofi S.A., Novartis Aktiengesellschaft, GlaxoSmithKline plc, Toray Industries Inc., CSL Behring LLC, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Ipsen S.A., Incyte Corporation, Cipla Limited, H. Lundbeck A/S, Sumitomo Pharma Co. Ltd., Mallinckrodt Pharmaceuticals plc, Kissei Pharmaceutical Co. Ltd., Asana BioSciences LLC, Vanda Pharmaceuticals Inc., Dermavant Sciences Inc., Galderma Laboratories L.P., Cara Therapeutics Inc., Avior Bio Inc., Trevi Therapeutics Inc.

North America was the largest region in the chronic pruritus therapeutics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chronic pruritus therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chronic pruritus therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic pruritus therapeutics market consists of sales of capsaicin creams, jak inhibitors, systemic therapies, phototherapy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Pruritus Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic pruritus therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic pruritus therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic pruritus therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Corticosteroid; Antihistamine; Local Anesthetic; Counterirritant; Immunosuppressant; Calcineurin Inhibitors; Other Product Types
• 2) By Disease Type: Atopic Dermatitis; Allergic Contact Dermatitis; Urticaria; Other Disease Types
• 3) By Distribution Channel: Hospital Pharmacies; Drug stores And Retail Pharmacies; Online Providers
• Subsegments:
• 1) By Corticosteroid: Topical Corticosteroids; Oral Corticosteroids; Injectable Corticosteroids
• 2) By Antihistamine: First-Generation Antihistamines; Second-Generation Antihistamines
• 3) By Local Anesthetic: Topical Local Anesthetics; Injectable Local Anesthetics
• 4) By Counterirritant: Menthol-Based Counterirritants; Camphor-Based Counterirritants
• 5) By Immunosuppressant: Systemic Immunosuppressants; Topical Immunosuppressants
• 6) By Calcineurin Inhibitors: Tacrolimus-Based Therapy; Pimecrolimus-Based Therapy
• 7) By Other Product Types: Biologic Therapies; Emerging Novel Therapies
• Companies Mentioned: Pfizer Incorporated; AbbVie Inc.; Sanofi S.A.; Novartis Aktiengesellschaft; GlaxoSmithKline plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chronic Pruritus Therapeutics Market Characteristics

3. Chronic Pruritus Therapeutics Market Trends And Strategies

4. Chronic Pruritus Therapeutics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Chronic Pruritus Therapeutics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Chronic Pruritus Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Chronic Pruritus Therapeutics Market Growth Rate Analysis
• 5.4. Global Chronic Pruritus Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Chronic Pruritus Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Chronic Pruritus Therapeutics Total Addressable Market (TAM)

6. Chronic Pruritus Therapeutics Market Segmentation

• 6.1. Global Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroid
• Antihistamine
• Local Anesthetic
• Counterirritant
• Immunosuppressant
• Calcineurin Inhibitors
• Other Product Types
• 6.2. Global Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Atopic Dermatitis
• Allergic Contact Dermatitis
• Urticaria
• Other Disease Types
• 6.3. Global Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Drug stores And Retail Pharmacies
• Online Providers
• 6.4. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Corticosteroid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Corticosteroids
• Oral Corticosteroids
• Injectable Corticosteroids
• 6.5. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Antihistamine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• First-Generation Antihistamines
• Second-Generation Antihistamines
• 6.6. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Local Anesthetic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Local Anesthetics
• Injectable Local Anesthetics
• 6.7. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Counterirritant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Menthol-Based Counterirritants
• Camphor-Based Counterirritants
• 6.8. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Immunosuppressant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Systemic Immunosuppressants
• Topical Immunosuppressants
• 6.9. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tacrolimus-Based Therapy
• Pimecrolimus-Based Therapy
• 6.10. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologic Therapies
• Emerging Novel Therapies

7. Chronic Pruritus Therapeutics Market Regional And Country Analysis

• 7.1. Global Chronic Pruritus Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Chronic Pruritus Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Pruritus Therapeutics Market

• 8.1. Asia-Pacific Chronic Pruritus Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Pruritus Therapeutics Market

• 9.1. China Chronic Pruritus Therapeutics Market Overview
• 9.2. China Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Pruritus Therapeutics Market

• 10.1. India Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Pruritus Therapeutics Market

• 11.1. Japan Chronic Pruritus Therapeutics Market Overview
• 11.2. Japan Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Pruritus Therapeutics Market

• 12.1. Australia Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Pruritus Therapeutics Market

• 13.1. Indonesia Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Pruritus Therapeutics Market

• 14.1. South Korea Chronic Pruritus Therapeutics Market Overview
• 14.2. South Korea Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Pruritus Therapeutics Market

• 15.1. Western Europe Chronic Pruritus Therapeutics Market Overview
• 15.2. Western Europe Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Pruritus Therapeutics Market

• 16.1. UK Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Pruritus Therapeutics Market

• 17.1. Germany Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Pruritus Therapeutics Market

• 18.1. France Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Pruritus Therapeutics Market

• 19.1. Italy Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Pruritus Therapeutics Market

• 20.1. Spain Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Pruritus Therapeutics Market

• 21.1. Eastern Europe Chronic Pruritus Therapeutics Market Overview
• 21.2. Eastern Europe Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Pruritus Therapeutics Market

• 22.1. Russia Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Pruritus Therapeutics Market

• 23.1. North America Chronic Pruritus Therapeutics Market Overview
• 23.2. North America Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Pruritus Therapeutics Market

• 24.1. USA Chronic Pruritus Therapeutics Market Overview
• 24.2. USA Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Pruritus Therapeutics Market

• 25.1. Canada Chronic Pruritus Therapeutics Market Overview
• 25.2. Canada Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Pruritus Therapeutics Market

• 26.1. South America Chronic Pruritus Therapeutics Market Overview
• 26.2. South America Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Pruritus Therapeutics Market

• 27.1. Brazil Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Pruritus Therapeutics Market

• 28.1. Middle East Chronic Pruritus Therapeutics Market Overview
• 28.2. Middle East Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Pruritus Therapeutics Market

• 29.1. Africa Chronic Pruritus Therapeutics Market Overview
• 29.2. Africa Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Pruritus Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Chronic Pruritus Therapeutics Market Competitive Landscape
• 30.2. Chronic Pruritus Therapeutics Market Company Profiles
  • 30.2.1. Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Pruritus Therapeutics Market Other Major And Innovative Companies

• 31.1. Toray Industries Inc.
• 31.2. CSL Behring LLC
• 31.3. Regeneron Pharmaceuticals Inc.
• 31.4. Astellas Pharma Inc.
• 31.5. Ipsen S.A.
• 31.6. Incyte Corporation
• 31.7. Cipla Limited
• 31.8. H. Lundbeck A/S
• 31.9. Sumitomo Pharma Co. Ltd.
• 31.10. Mallinckrodt Pharmaceuticals plc
• 31.11. Kissei Pharmaceutical Co. Ltd.
• 31.12. Asana BioSciences LLC
• 31.13. Vanda Pharmaceuticals Inc.
• 31.14. Dermavant Sciences Inc.
• 31.15. Galderma Laboratories L.P.

32. Global Chronic Pruritus Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Pruritus Therapeutics Market

34. Recent Developments In The Chronic Pruritus Therapeutics Market

35. Chronic Pruritus Therapeutics Market High Potential Countries, Segments and Strategies

• 35.1 Chronic Pruritus Therapeutics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Chronic Pruritus Therapeutics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Chronic Pruritus Therapeutics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer